title: [Thrombopenia during 5-ASA treatment (mesalazine and olsalazine)].
authors.forename: R
authors.initials: R
authors.lastname: Benoit
authors.forename: O
authors.initials: O
authors.lastname: Grobost
authors.forename: A
authors.initials: A
authors.lastname: Bichoffe
authors.forename: L
authors.initials: L
authors.lastname: Dol
mesh_terms: D000293:Adolescent; D000636:Aminosalicylic Acids / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019804:Mesalamine / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine; C032587:olsalazine
vernacular_title: Thrombopénie au cours d'un traitement par 5-ASA (mésalazine puis olsalazine).